Publication | Open Access
Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer
32
Citations
0
References
2019
Year
Breast OncologyOncologyMedicineBreast CancerAnti-cancer AgentPhase Iii StudyCancer TreatmentPharmacologyRadiation OncologyMolecular Oncology
No additional data available for this publication yet. Check back later!